MITCHELL KENNEDY TO LEAD THE JACKSON LABORATORY'S JAX® MICE, CLINICAL AND RESEARCH SERVICES BUSINESS
Retrieved on:
Tuesday, April 4, 2023
Zoology, Mouse, Drug development, CMD, Applied Biosystems, Therapy, Genetic engineering, University, Berkeley, Marketing, Marine biology, Cancer, Chromatography, Oregon Institute of Marine Biology, Research, Thermo Fisher Scientific, Mass spectrometry, Oregon Institute, Jackson Laboratory, IVF, Cryopreservation, Organization, Bio-Rad Laboratories, University of Oregon, Fellow of the Academy of Medical Sciences, JAX, PerkinElmer, Mitchell, BAR, Affymetrix, Management
Approximately 2,400 organizations in 68 countries rely on over 13,000 strains of genetically-specialized JAX® Mice and research services in a wide range of therapeutic areas.
Key Points:
- Approximately 2,400 organizations in 68 countries rely on over 13,000 strains of genetically-specialized JAX® Mice and research services in a wide range of therapeutic areas.
- In addition, JAX provides a variety of services to the research community including preclinical in-vivo pharmacology services, mouse model generation (e.g., genetic engineering), custom breeding services, assisted reproductive technologies (e.g., cryopreservation and IVF services), and cancer genomic testing services.
- In this position, Kennedy will drive product development, business development, business unit management, marketing, field representation, and customer support for JMCRS, as well as lead all JMCRS operational groups.
- "The Jackson Laboratory's scientific and academic reputation precedes itself, and I have admired the organization throughout my entire career," said Kennedy.